Nakayo
6715
Agora Hospitality Group
9704
Kawasaki Geological Engineering
4673
GFA
8783
Sunwels
9229
JP Stock MarketDetailed Quotes
4570 Immuno-Biological Laboratories
- 566
- +59+11.64%
20min DelayTrading Feb 19 15:00 JST
5.27BMarket Cap28.23P/E (Static)
602High556Low1.78MVolume601Open507Pre Close1.03BTurnover64952wk High25.20%Turnover Ratio9.31MShares35852wk Low24.85EPS TTM3.99BFloat Cap4400Historical High28.23P/E (Static)7.06MShs Float75Historical Low20.05EPS LYR9.07%Amplitude--Dividend TTM3.94P/B100Lot Size--Div YieldTTM
Immuno-Biological Laboratories Key Stats
EPS
According to the latest financial report of Immuno-Biological Laboratories, the latest earnings per share (TTM) for the company is 17.84. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about Immuno-Biological Laboratories's free cash flow? The latest report shows it as 76.07M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Immuno-Biological Laboratories shows that the company's current ratio is 4.75, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Immuno-Biological Laboratories, the quick ratio is 3.47, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of Immuno-Biological Laboratories? The latest ROE figure is 14.05%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Immuno-Biological Laboratories, the total asset return on investment (ROA) is 10.88%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Immuno-Biological Laboratories's latest financial report to see how their gross margin is doing - currently at 71.10%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Immuno-Biological Laboratories, the net profit margin is 61.91%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...